Stephen Dale serves as Executive at Kura Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Stephen Dale has executed 7 insider transactions totaling $359.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 30, 2024 involved selling 4,825 shares valued at $104.0K.
Stephen Dale currently holds 38,817 shares of Kura Oncology, Inc. (KURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Dale has been a net seller of KURA stock. They have purchased $0 and sold $359.4K worth of shares.
Stephen Dale's most recent insider trade was on Jan 30, 2024, when they sold 4,825 shares at $21.55 per share.
Get notified when new Form 4 filings are submitted
| $17.80 |
| Discretionary |
| Jan 29, 2024 | KURA | $78.3K | Sale | 4,400 | $17.80 | Discretionary |
| Feb 16, 2023 | KURA | $0 | Award | 23,125 | $N/A | Discretionary |
| Jan 27, 2023 | KURA | $60.9K | Sale | 4,385 | $13.89 | Discretionary |
| Jan 27, 2023 | KURA | $67.1K | Sale | 4,840 | $13.87 | Discretionary |
| Jan 26, 2022 | KURA | $0 | Award | 36,900 | $N/A | Discretionary |